Dissolution, HSPM, PXRD, DSC studies on gastro retentive multi-particulates of metformin hydrochloride for the treatment of diabetes using gelucire

Metformin hydrochloride (MH), an important drug in the treatment of type II diabetes mellitus, requires multiple administration in 500-1500 mg doses/day. Sustained release gastro retentive multiparticulates of MH were prepared by dispersing drug in melted gelucire 39/01 and 43/01 using the melt granulation technique. Hot stage polarized microscopy, powder X-ray diffraction and differential scanning calorimetry thermograms were conducted to test crystallinity of MH and significant decrease in crystallinity was found. The percent drug entrapment in matrices was around 99.8 %. The multi-particulates demonstrated favorable in vitro floating ability for 11 h. Evaluation for in vitro drug release data analysis was performed using PCP-Disso software. Prepared formulations followed zero order kinetics and drug release mechanism was anomalous diffusion controlled. The combination of ethylcellulose, methylcellulose and microcrystalline cellulose with gelucire were noted for release of drug, floatability and consistency for optimized formulation. It was concluded that matrices of gelucire 39/01 and 43/01 may serve as effective carriers for highly water-soluble drugs for controlled delivery as compared to release profile with marketed sustained release productColegio de Farmacéuticos de la Provincia de Buenos Aire